Vaccine composition for classical swine fever and preparation method thereof
AssigneesBioapplications Inc., Republic of Korea (Animal and Plant Quarantine Agency)
InventorsYongjik LEE, Dong-Jun AN, Se Eun CHOE, Jae-Young SONG, In-Soo CHO
Life of this patent
Estimating the term…
Abstract
Provided is a swine fever antigen fused with a porcine Fc fragment, and more particularly, to a vaccine composition having an autoimmune-enhancing effect by binding the Fc fragment to a swine fever antigen, and a preparation method thereof.
Claims16
-16. (canceled)
A method for preventing or treating classical swine fever, comprising administering to a subject in need thereof a composition comprising a classical swine fever antigen E2 protein fused with a porcine Fc fragment represented by SEQ ID No. 4 as an active ingredient.
A recombinant vector for producing a classical swine fever antigen E2 protein fused with an Fc fragment, comprising a polynucleotide encoding a porcine Fc fragment represented by SEQ ID No. 4 and a polynucleotide encoding a classical swine fever antigen E2 protein.
A vaccine composition for preventing classical swine fever, comprising a classical swine fever antigen E2 protein fused with a porcine Fc fragment represented by SEQ ID No. 4 as an active ingredient.
A feed composition for preventing classical swine fever, comprising a classical swine fever antigen E2 protein fused with a porcine Fc fragment represented by SEQ ID No. 4 as an active ingredient.
Dependencies are inferred from the claim text.